It has been widely recognized that NF‐κB is a key transcriptional factor related to pro‐tumorigenic effects, including survival, EMT, metastasis of cancer cells, and inflammation of the tumor microenvironment [45, 46, 47]. Here, NFKB1 is linked to cancer.